Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    National Security
    Science & Regulatory
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Investor Forum
    BIO Asia-Taiwan

    July 15-19, 2026
    Taipei, Taiwan

    BIO Patient & Health Advocacy Summit
    BIO Patient Advocacy Changemakers Event

    October 22-23, 2026
    Washington, D.C

    BIO Asia-Taiwan
    BIO Europe

    November 9-11, 2026
    Cologne, Germany

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyNational SecurityScience & RegulatoryAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3199 results found
Expand All
Apply All
3199 results found

What USTR and HHS said on Capitol Hill
Share
Bio.News  •  March 24, 2023
Happy Friday. A busy week on Capitol Hill concludes with hearings covering key issues including Mexico’s biotech corn ban, expanding the COVID IP waiver, and upholding the purpose of Bayh-Dole—we have a quick recap. (641 words, 3 minutes, 12 seconds)
Read More

‘Innovations like our vaccine can only happen in America’
Share
Bio.News  •  March 23, 2023
A busy week continues with yesterday’s hearings on the price of Moderna’s COVID-19 vaccine, the proposed HHS budget, and important PBM transparency legislation—with lots of discussion on priority issues for BIO members. Highlights below—plus, what we would ask USTR today. (733 words, 3 minutes, 39 seconds)
Read More

BIO One-on-One Partnering™ Resources
Share
BIO One-on-One Partnering is the most efficient way to do business in the biotech and pharma industry without traveling all over the world. Our system makes it easy to search for and identify potential partners and request meetings with prospective biotech investors and senior business development executives. You can communicate directly with prospective biotech investors and senior business and scientific management executives attending BIO’s events. You can invite companies and accept invitations to meet, and once your meetings are mutually accepted, you can self-schedule them at a time of your choosing.
Read More

Inquiry Form for Brex Financial Services
Share
BIO Business Solutions
BIO Business Solutions® is the largest cost savings purchasing program for the biotech industry operated by the Biotechnology Innovation Organization (BIO). With more than half a billion in annual sales, BIO Business Solutions® aggregates the purchasing power of over 4,700 life science companies from North America. Companies of all sizes save substantial money each year through this cost-savings program. To request information on the BIO-Brex cost-savings program, please fill the fields below and click the Submit button at the bottom of the form.   MktoForms2.loadForm("//app-ab15.marketo.com", "490-EHZ-999", 3799);  
Read More

Inquiry Form for ADP R&D Tax Credit Offering
Share
BIO Business Solutions
BIO Business Solutions® is the largest cost savings purchasing program for the biotech industry operated by the Biotechnology Innovation Organization (BIO). With more than half a billion in annual sales, BIO Business Solutions® aggregates the purchasing power of over 4,700 life science companies from North America. Companies of all sizes save substantial money each year through this cost-savings program. To request information for the ADP R&D Tax Credit Offering, please fill the fields below and click the Submit button at the bottom of the form.   MktoForms2.loadForm("//app-ab15.marketo.com", "490-EHZ-999", 3727);  
Read More

What we're watching in today's Senate HELP hearing
Share
Bio.News  •  March 22, 2023
A busy day includes the Senate HELP Committee hearing with Moderna—here’s what we’re watching. Plus, today is World Water Day—and the first major UN water conference since the 1970s—so we’re looking at the role for biotech. (628 words, 3 minutes, 8 seconds)
Read More

Cell and Gene Therapy BETA DRAFT
Share
Cell and gene therapy (CGT) products have the potential to cure intractable diseases, bring hope and meaningful benefit to patients in need, and change the way we approach treating disease.  These therapies often target rare diseases and conditions, where patients often have limited treatment options.  As the CGT product development cycle presents unique challenges and opportunities, BIO is engaging in regulatory advocacy efforts across the product lifecycle.  Here you will find BIO consensus documents describing policy positions on a variety of topics, from nonclinical to manufacturing and clinical phases. 
Read More

4 questions with Moderna – plus, how we're ending animal testing
Share
Bio.News  •  March 21, 2023
It’s a busy Tuesday in a busy week. We’re gearing up for an important hearing on the value of biotech tomorrow and exploring how FDA and the industry are seeking to end animal testing. Plus, it’s National Ag Day AND International Day of Forests—and biotech has a role in both. (799 words, 3 minutes, 59 seconds)
Read More

IP waiver would ‘disrupt’ innovation, preparedness, jobs
Share
Bio.News  •  March 20, 2023
Comments were due Friday to the USITC on the proposed expansion of the COVID IP waiver—here’s what BIO and CSBA said. Plus, it’s been a year since the USDA has required labeling for bioengineered foods—and it appears consumer choices haven’t changed much. (664 words, 3 minutes, 19 seconds)
Read More

CSBA letter to USITC Expressing Concerns with Proposed WTO TRIPS Waiver Expansion
Share
Patient Advocacy, Council for State Biotechnology Associations (CSBA)  •  Letters, Testimony & Comments  •  March 17, 2023

Pagination

  • First First page
  • Prev Previous page
  • …
  • 114
  • 115
  • 116
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO